Clinuvel Pharmaceuticals Limited
CLVLF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $22,097 | $14,075 | $24,700 | $10,936 |
| Dep. & Amort. | $574 | $608 | $567 | $575 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,009 | $0 | $5,643 |
| Change in WC | $0 | $0 | -$5,061 | $0 |
| Other Non-Cash | $5,272 | -$2,540 | -$9,532 | $9,225 |
| Operating Cash Flow | $27,943 | $13,152 | $10,674 | $26,380 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$241 | -$58 | -$275 | -$5,302 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$17,475 | $0 | $0 | -$10,711 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$29,943 | -$12,746 | $0 |
| Investing Cash Flow | -$17,715 | -$30,001 | -$13,021 | -$16,013 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$187 | $0 | -$164 |
| Stock Issued | $189 | $0 | $0 | $0 |
| Stock Repurch. | -$189 | -$252 | -$4,909 | $0 |
| Dividends Paid | -$1 | -$2,503 | $0 | -$2,470 |
| Other Fin. Act. | $4 | $0 | $3,972 | $0 |
| Financing Cash Flow | $4 | -$2,942 | -$937 | -$2,634 |
| Forex Effect | $969 | $1,411 | -$332 | -$404 |
| Net Chg. in Cash | $11,200 | $16,821 | -$3,616 | $14,950 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16,821 | $0 | $38,817 | $23,867 |
| End Cash | $28,021 | $16,821 | $35,201 | $38,817 |
| Free Cash Flow | $27,702 | $13,094 | $10,399 | $21,078 |